Doctors

Melbourne Pathology - Victoria's Premier Medical Testing Laboratory

Investigative Protocols

Home | Doctors | Investigative Protocols

The relevant investigative protocol and/or patient note may be attached to your patient's printed or electronic result.

The range of investigative protocols cover conditions associated with:
Clinical Conditions
Abbreviation IP Title
Female - androgen excess/hirsutism Evaluation of possible androgen excess and/or hirsutism (females)
Female - infertility Evaluation of female infertility
Female - menstruation Evaluation of irregular periods
Female - menstrual hormones (comb) Hormonal changes during menstrual cycle - combined
Female - menstrual hormones (ea) Hormonal changes during menstrual cycle by each hormone
Hyperprolactinaemia Causes of hyperprolactinaemia (prolactin > 700 mIU/L)
Back to Top
Coagulation Tests
Abbreviation IP Title
Platelet Platelet function analysis
Thrombosis Risk factors for venous thromboembolism
vWF1 von Willebrand disease
Back to Top
Drug Screen Interpretation
Abbreviation IP Title
Methadone Evaluation of EDDP (methadone metabolite) results
THC Evaluation of 9-tetrahydrocannabinol (THC) results
UDS Urine drug screening
UDS Amph Evalution of sympathomimetic amine results
UDS Benzo Evaluation of benzodiazepine results
UDS Cocaine Evaluation of cocaine results
UDS Opiate Evaluation of opiate results
UDS TLC Thin layer chromotography
Back to Top
Endocrine Tests
Abbreviation IP Title
Cush Evaluation of Cushing's syndrome - see flowchart
TSH High Evaluation of an elevated serum TSH (> 4.0 mU/L)
TSH Low Evaluation of a subnormal serum TSH (< 0.2 mU/L)
Back to Top
General Biochemistry
Abbreviation IP Title
Bicarb Low Causes of low plasma bicarbonate (bicarbonate < 18)
Hypercalcaemia - causes Causes of hypercalcaemia (calcium > 2.6)
Hypercalcaemia - evaluation Evaluation of hypercalcaemia (calcium > 2.6)
Hypocalcaemia - evaluation Evaluation of hypocalcaemia (calcium < 2.2)
CK raised - evaluation Causes of an elevated CK (M > 200 F > 140)
Hyperglobulinaemia - evaluation Evaluation of hyperglobulinaemia (globulins > 44)
Hypoglycaemia - evaluation Evaluation of hypoglycaemia (plasma glucose < 2.8 mmol/L)
LDI - evaluation Evaluation of Lactate Dehydrogenase Isoenzymes (LDI)
MI - changes in enzymes Cardiac enzyme changes during myocardial infarction
Hypomagnesaemia - causes Causes of hypomagnesaemia (magnesium < 0.7mmol/L)
Hyperphosphataemia - causes Causes of hyperphosphataemia (phosphate > 1.8)
Hypophosphataemia - causes Causes of hypophosphataemia (mild 0.5~0.65 mmol/L; severe < 0.4 mmol/L)
Polyuria - evaluation Evaluation of polyuria (urine volume > 3L/24hrs)
Hyperkalaemia - causes Causes of hyperkalaemia (potassium > 5.0)
Hyperkalaemia - evaluation Evaluation of hyperkalaemia (potassium > 5.0)
Hypokalaemia - causes Causes of hypokalaemia (potassium < 3.0)
Hypokalaemia - evaluation Evaluation of hypokalaemia (potassium < 3.0)
Hyponatraemia - causes Causes of hyponatraemia (sodium < 130)
Hyperuricaemia - evaluation Evaluation of hyperuricaemia (M > 0.45 F > 0.40)
Back to Top
Immunology
Abbreviation IP Title
Plasma Cell Dys Evaluation of plasma cell dyscrasias
IgM Plasma Cell Dys Evaluation of IgM plasma cell dyscrasias
Coeliac Coeliac disease investigation
IgA deficiency Evaluation of selective IgA deficiency
Back to Top
Liver Function Tests
Abbreviation IP Title
ALP elevation - causes Causes of an Isolated serum Alkaline Phosphatase (ALP) elevation (ALP > 180 IU/L)
ALP High - elevation Evaluation of ALP elevation (ALP > 180 IU/L)
ALP isolated high - evaluation Evaluation of an isolated serum ALP elevation - query growth related (age < 19 yrs)
ALP High - growth related Serum ALP elevation - query growth related (age < 19 yrs). See flowchart
ALP - High < 5 yo Marked serum ALP elevation (ALP > 700 IU/L age < 5 yrs)
GGT High - causes Causes of an elevated serum Gamma Glutamyl Transferase (GGT) (GGT > 100 U/L)
LD High - evaluation Evaluation of an elevated serum Lactate Dehydrogenase (LD) (LD > 300 U/L)
Aminotransferase - evaluation Evaluation of a moderate elevation of aminotransferase levels (AST & ALT)
Hepatocellular pathology Predominant hepatocellular pathology (ALT or AST > 150 U/L ALP < 200 U/L)
Atypical LFT Evaluation of a LFT pattern not typical of liver disease (elevated LD, AST > ALT)
Hyperbilirubinaemia - causes Causes of an isolated hyperbilirubinaemia (bilirubin > 25 mmol/L)
Hyperbilirubinaemia - evaluation Evaluation of an isolated hyperbilirubinaemia (bilirubin > 30 mmol/L)
Jaundice - evaluation Evaluation of jaundice (ALT < 400 U/L ALP > 350 U/L)
Jaundice - evaluation 2 Evaluation of jaundice (ALT > 300 U/L ALP < 350 U/L)
Cholestasis - evaluation Evaluation of localised cholestasis (ALP > 180 U/L ALT < 150 U/L GGT > 100 U/L bilirubin < 50 umol/L)
Cholestatic Disease Evaluation of mixed hepatocellular and cholestatic disease (ALP > 180 U/L GGT > 65 U/L ALT or AST > 150 U/L)
Back to Top
Microbiology & Patient Notes
Abbreviation IP Title
Haematuria - causes Causes of isolated microscopic haematuria
Occult blood Faecal occult blood
Barmah Forest virus Symptoms, incubation, treatment and prevention of Barmah Forest virus
Blastocystosis Symptoms, infection period, diagnosis, treatment and prevention of blastocystosis
Cryptosporidiosis Symptoms, infection period, spread of infection and treatment of cryptosporidiosis
Giardiasis Symptoms, infection period, spread of infection, diagnosis, treatment and prevention of giardiasis
Listeriosis Symptoms, causes, infection period, diagnosis, treatment and prevention of listeriosis
Parvovirus Causes, infection period, spread of infection, diagnosis, treatment and prevention of parvovirus
Ross River virus Symptoms, infection period, spread of infection, diagnosis, treatment and prevention of Ross River virus
Back to Top
Serology
Abbreviation IP Title
Hep A & ALT Serological events in acute (self-limiting) Hepatitis A infection relative to Alanine Aminotransferase (ALT) peak
Hep B & ALT Serological events in acute (self-limiting) Hepatitis B infection relative to ALT peak
Hep B Hepatitis B immune status
Pertussis Treatment of Bordetella pertussis
Back to Top
Warfarin Management
Abbreviation IP Title
INR Ranges Range of International Normalised Ratio (INR) recommended for specific applications of warfarin therapy
INR - management Guidelines to the management of an elevated INR, with or without bleeding
Warfarin - Risk Factors Risk factors for bleeding complications of warfarin therapy
Back to Top